The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging

Psychiatry Research - Neuroimaging

Volumn 222, Issue 1-2, 2014, Pages 84-90

  Marano, Christopher M ^a   Workman, Clifford I ^a   Lyman, Christopher H ^a   Kramer, Elisse ^b   Hermann, Carol R ^b   Ma, Yilong ^c   Dhawan, Vijay ^c   Chaly, Thomas ^c   Eidelberg, David ^c   Smith, Gwenn S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c Northwell Health   (United States)

Author keywords

Fasting blood glucose; FDG PET; Insulin resistance; Late life depression; Normal aging

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FASTING SERUM GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; LATE LIFE DEPRESSION; MALE; MOTOR CORTEX; NEUROBIOLOGY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SENSORY CORTEX;

FASTING BLOOD GLUCOSE; FDG PET; INSULIN RESISTANCE; LATE-LIFE DEPRESSION; NORMAL AGING;

ADULT; AGED; AGING; BLOOD GLUCOSE; CEREBRAL CORTEX; DEPRESSIVE DISORDER; FASTING; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 84908500498     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2014.01.009     Document Type: Article

References (45)

1. Abbatecola A.M., Paolisso G., Lamponi M., Bandinelli S., Lauretani F., Launer L., Ferrucci L. Insulin resistance and executive dysfunction in older persons. Journal of the American Geriatrics Society 2004, 52:1713-1718.
2. Alexopoulos G.S. The depression-executive dysfunction syndrome of late life: a specific target for D3 agonists?. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 2001, 9:22-29.
3. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. Vascular depression hypothesis. Archives of General Psychiatry 1997, 54:915-922.
4. Alexopoulos G.S., Meyers B.S., Young R.C., Mattis S., Kakuma T. The course of geriatric depression with "reversible dementia": a controlled study. American Journal of Psychiatry 1993, 150:1693-1699.
5. Alexopoulos G.S., Vrontou C., Kakuma T., Meyers B.S., Young R.C., Klausner E., Clarkin J. Disability in geriatric depression. American Journal of Psychiatry 1996, 153:877-885.
6. Alexopoulos G.S., Young R.C., Meyers B.S. Geriatric depression: age of onset and dementia. Biological Psychiatry 1993, 34:141-145.
7. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2013, 36(Suppl. 1):S67-S74.
8. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer[U+05F3]s disease. Cerebral Cortex 1991, 1:103-116.
9. Baker L.D., Cross D.J., Minoshima S., Belongia D., Watson G.S., Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Archives of Neurology 2011, 68:51-57.
10. Bartlett E.J., Brodie J.D., Wolf A.P., Christman D.R., Laska E., Meissner M. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 1988, 8:502-512.
11. Bhalla R.K., Butters M.A., Mulsant B.H., Begley A.E., Zmuda M.D., Schoderbek B., Pollock B.G., Reynolds C.F., Becker J.T. Persistence of neuropsychologic deficits in the remitted state of late-life depression. American Journal of Geriatric Psychiatry 2006, 14:419-427.
12. Burns C.M., Chen K., Kaszniak A.W., Lee W., Alexander G.E., Bandy D., Fleisher A.S., Caselli R.J., Reiman E.M. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology 2013, 80:1557-1564.
13. Conwell Y., Duberstein P.R., Cox C., Herrmann J.H., Forbes N.T., Caine E.D. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. American Journal of Psychiatry 1996, 153:1001-1008.
14. Craft S., Asthana S., Schellenberg G., Cherrier M., Baker L.D., Newcomer J., Plymate S., Latendresse S., Petrova A., Raskind M., Peskind E., Lofgreen C., Grimwood K. Insulin metabolism in Alzheimer[U+05F3]s disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 1999, 70:146-152.
15. Craft S., Baker L.D., Montine T.J., Minoshima S., Watson G.S., Claxton A., Arbuckle M., Callaghan M., Tsai E., Plymate S.R., Green P.S., Leverenz J., Cross D., Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology 2012, 69:29-38.
16. Craft S., Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 2004, 3:169-178.
17. Dhamoon M.S., Noble J.M., Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2009, 72:292-293. (author reply 293-294).
18. Diaconescu A.O., Kramer E., Hermann C., Ma Y., Dhawan V., Chaly T., Eidelberg D., McIntosh A.R., Smith G.S. Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression. Human Brain Mapping 2011, 32:1677-1691.
19. Eaton W.W., Armenian H., Gallo J., Pratt L., Ford D.E. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996, 19:1097-1102.
20. First, M., Spitzer, R., Williams, J., Gibbon, M., 1995. Structured Clinical Interview for DSM-IV-Non-Patient Edition (SCID-NP, Version 1.0), American Psychiatric Press, Washington, DC.
21. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
22. Goldberg S., Smith G.S., Barnes A., Ma Y., Kramer E., Robeson K., Kirshner M., Pollock B.G., Eidelberg D. Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiology of Aging 2004, 25:167-174.
23. Haan M.N. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer[U+05F3]s disease. Nature Clinical Practice. Neurology 2006, 2:159-166.
24. Hennings J.M., Ising M., Grautoff S., Himmerich H., Pollmacher T., Schaaf L. Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association 2010, 118:98-100.
25. Henriksson M.M., Marttunen M.J., Isometsa E.T., Heikkinen M.E., Aro H.M., Kuoppasalmi K.I., Lonnqvist J.K. Mental disorders in elderly suicide. International Psychogeriatrics 1995, 7:275-286.
26. Krishnan K.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. The American Journal of Psychiatry 1997, 154:497-501.
27. Langbaum J.B., Chen K., Lee W., Reschke C., Bandy D., Fleisher A.S., Alexander G.E., Foster N.L., Weiner M.W., Koeppe R.A., Jagust W.J., Reiman E.M., Alzheimer's Disease Neuroimaging Initiative Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage 2009, 45:1107-1116.
28. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians 1976, 77-121. Grune & Stratton, New York. L. Bellak, T. Karasu (Eds.).
29. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
30. Menna-Perper M., Rochford J., Mueller P.S., Swartzburg M., Jekelis A.W., Manowitz P. Differential response of plasma glucose, amino acids and nonesterified fatty acids to insulin in depressed patients. Psychoneuroendocrinology 1984, 9:161-171.
31. Mueller P.S., Heninger G.R., McDonald R.K. Insulin tolerance test in depression. Archives of General Psychiatry 1969, 21:587-594.
32. Nathan R.S., Sachar E.J., Asnis G.M., Halbreich U., Halpern F.S. Relative insulin insensitivity and cortisol secretion in depressed patients. Psychiatry Research 1981, 4:291-300.
33. Okamura F., Tashiro A., Utumi A., Imai T., Suchi T., Tamura D., Sato Y., Suzuki S., Hongo M. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism: Clinical and Experimental 2000, 49:1255-1260.
34. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Archives of General Psychiatry 2006, 63:530-538.
35. Pasquier F., Boulogne A., Leys D., Fontaine P. Diabetes mellitus and dementia. Diabetes & Metabolism 2006, 32:403-414.
36. Rasgon N., Jarvik L. Insulin resistance, affective disorders, and Alzheimer[U+05F3]s disease: review and hypothesis. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004, 59:M178-183.
37. Reger M.A., Watson G.S., Frey W.H., Baker L.D., Cholerton B., Keeling M.L., Belongia D.A., Fishel M.A., Plymate S.R., Schellenberg G.D., Cherrier M.M., Craft S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiology of Aging 2006, 27:451-458.
38. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer[U+05F3]s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. The New England Journal of Medicine 1996, 334:752-758.
39. Schmidt R., Fazekas F., Kleinert G., Offenbacher H., Gindl K., Payer F., Freidl W., Niederkorn K., Lechner H. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Archives of Neurology 1992, 49:825-827.
40. Sims-Robinson C., Kim B., Rosko A., Feldman E.L. How does diabetes accelerate Alzheimer disease pathology?. Nature Reviews. Neurology 2010, 6:551-559.
41. Smith G.S., Kramer E., Hermann C., Ma Y., Dhawan V., Chaly T., Eidelberg D. Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biological Psychiatry 2009, 66:259-266.
42. Smith G.S., Kramer E., Ma Y., Kingsley P., Dhawan V., Chaly T., Eidelberg D. The functional neuroanatomy of geriatric depression. International Journal of Geriatric Psychiatry 2009, 24:798-808.
43. Takikawa S., Dhawan V., Spetsieris P., Robeson W., Chaly T., Dahl R., Margouleff D., Eidelberg D. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993, 188:131-136.
44. Weber-Hamann B., Gilles M., Schilling C., Onken V., Frankhauser P., Kopf D., Lederbogen F., Deuschle M. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. Journal of Clinical Psychopharmaclogy 2008, 28:581-584.
45. Winokur A., Maislin G., Phillips J.L., Amsterdam J.D. Insulin resistance after oral glucose tolerance testing in patients with major depression. The American Journal of Psychiatry 1988, 145:325-330.